Press Releases
June 7, 2019
Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference
May 24, 2019
Surface Oncology Presents Preclinical Data Further Supporting Anti-Tumor Mechanism of CD73 and CD39 Programs at Brisbane Immunotherapy 2019
May 15, 2019
Surface Oncology to Present at Two Upcoming Healthcare Conferences
May 9, 2019
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2019
April 24, 2019
Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day
April 1, 2019
Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer
March 7, 2019
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2018
March 4, 2019
Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference
February 4, 2019
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388
January 16, 2019
Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins
Displaying 1 - 10 of 11